Squamous Cell Carcinoma Surgery

Book Consultation
Surgical Treatment at Swift Access Health

Squamous Cell Carcinoma (SCC) Surgery

Squamous cell carcinoma (SCC) is the second most common form of skin cancer, arising from the keratinocytes in the outer layer of the epidermis. It is most frequently found on sun-exposed areas including the face, scalp, ears, neck, hands, and lower legs. SCC grows more rapidly than basal cell carcinoma and carries a small but meaningful risk of spreading to regional lymph nodes and distant organs if left untreated — making prompt diagnosis and complete surgical removal essential.

At Swift Access Health, SCC is managed by a consultant dermatologist or plastic surgeon who is an expert in skin cancer and a member of a skin cancer multidisciplinary team – providing the best care. The primary treatment is surgical excision with appropriate margins, with reconstruction using skin flaps or skin grafts where the size or location requires it. For advanced or high-risk SCC, radiotherapy may be indicated. For SCC that cannot be removed by surgery because it is advanced, immunotherapy may be recommended by oncology colleagues.

Book Consultation

Info

Time

30–90 minutes depending on lesion size, location, and reconstruction required

Results

Complete surgical removal of SCC with histological confirmation; high cure rate for early disease

Risks

Bleeding, infection, scarring, nerve injury; further treatment if margins not clear — discussed pre-operatively

Recovery

1–2 weeks for initial wound healing; return to normal activities within 2 weeks for most patients

Anaesthetic

Local anaesthetic; general anaesthetic for complex facial reconstruction if required

Aftercare

Wound care, sun protection, histology follow-up, and long-term skin surveillance

Why Choose Swift Access Health

Benefits of SCC Surgery

Specialist surgical management of squamous cell carcinoma by a consultant dermatologist or plastic surgeon with dedicated skin cancer expertise ensures complete excision, accurate staging, and the best possible functional and cosmetic outcome.

  • Excision with NICE-guideline margins, verified by histological analysis of all specimens
  • Advanced reconstructive expertise for large SCC or those on the face requiring flap or skin graft closure
  • Coordination with oncology for radiotherapy or immunotherapy in high-risk or advanced disease
  • Assessment of draining regional lymph nodes — with surgical node clearance where spread is confirmed
  • Structured long-term surveillance with regular whole body skin checks and clinical review
Book Consultation
Your Patient Journey

1. Your
Consultation

Your surgeon will review any existing biopsy report, examine the lesion and regional lymph nodes, and perform a whole body skin check. They will arrange any required scans / imaging if indicated. The surgical plan — including excision margins, closure technique or reconstruction, and any requirement for further treatment such as radiotherapy— is explained fully. A personalised treatment plan is agreed before consent is obtained.

Your Patient Journey

2. Your
Treatment

Typically under local anaesthetic, the SCC is excised with an appropriate margin of healthy skin determined by tumour size and risk factors. Where the wound cannot be closed directly, reconstruction using local tissue rearrangement (skin flap) or a skin graft is performed. All excised tissue is sent to a specialist pathology laboratory to confirm complete margin clearance.

Your Patient Journey

3. Aftercare

Wound care instructions are provided and sutures removed after 7–14 days. Histology results are discussed at a follow-up appointment. If margins are clear, structured surveillance is arranged. If margins are involved or the tumour is high-risk, further surgery or referral for adjuvant radiotherapy is arranged promptly. Long-term sun protection and regular skin checks are essential for all patients.

Frequently Asked Questions

  • Both BCC and SCC are non-melanoma skin cancers arising from keratinocytes. BCC is more common and almost never spreads beyond the skin. SCC grows more rapidly and carries a small but real risk — typically around 3–5% for lower risk lesions — of spreading to lymph nodes. High-risk SCC (large, poorly differentiated, or arising in immunosuppressed patients) carries a higher risk and requires more aggressive management.

  • SCC commonly presents as a firm, red or skin-coloured nodule, a non-healing wound or ulcer, a crusty or scaly plaque, or a wart-like growth on sun-exposed skin. It often develops in areas of pre-existing sun damage or within actinic keratoses. Any persistent, growing, or non-healing skin lesion should be assessed by a dermatologist.

  • For most SCCs, surgical excision is the treatment of choice and offers the highest cure rate. For certain superficial, low-risk tumours — particularly in patients who are not suitable candidates for surgery — topical treatments, curettage, or radiotherapy may be considered. Your surgeon will recommend the most appropriate approach based on your specific tumour type and circumstances.

  • If lymph node involvement is confirmed on examination or imaging, surgical removal of the affected lymph nodes (lymphadenectomy) may be recommended. This may be followed by adjuvant radiotherapy and discussed with oncology colleagues. For inoperable disease, systemic immunotherapy is now available and has significantly improved outcomes.

  • Adjuvant radiotherapy following surgical excision is recommended for high-risk SCC — particularly those with involved or very close margins, perineural (nerve) invasion, large tumour size, or specific anatomical locations. Your surgeon will review the histology results and discuss with the oncology team whether adjuvant treatment is indicated.

  • Following SCC treatment, regular clinical skin examinations are recommended — typically every 3–6 months for the first 2 years, and then reduced thereafter. Patients with a history of SCC have a substantially increased risk of developing further skin cancers. Sun protection, self-examination, and prompt reporting of any new or changing lesions are important components of long-term follow-up.

Related Treatments

Treatments

skin cancer treatment

Treatments

Basal Cell carcinoma surgery